Apollo to Announce Third Quarter 2024 Financial Results on November 5, 2024
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) plans to release financial results for the third quarter […]
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA
TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a […]
Spirit Blockchain Capital executes a strategic agreement to acquire Dogecoin Portfolio Holdings Corp. and its underlying intellectual property
Please click to view image Vancouver, BC, Oct. 08, 2024 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (CSE: SPIR) (“Spirit” […]
Voltaiq and NOVONIX Announce Strategic Partnership to Drive Efficiency and Quality in the Battery Industry
HALIFAX, Nova Scotia, Oct. 08, 2024 (GLOBE NEWSWIRE) — Voltaiq, the industry leader in battery quality analytics software, and NOVONIX […]
Axalta Schedules Third-Quarter 2024 Earnings Conference Call
PHILADELPHIA, Oct. 08, 2024 (GLOBE NEWSWIRE) — Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its […]
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
SARASOTA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) — Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments […]
Enact to Host Third Quarter 2024 Earnings Call November 7th
RALEIGH, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its third […]
Yoshiharu Announces Strategic Partnership with Xing Sheng Group to Open Flagship Restaurant in Shenyang, China
Agreement with Xing Sheng Group will Bring Yoshiharu Global’s Expanding Cuisine to its First International Location BUENA PARK, Calif., Oct. […]
Runway Growth Finance Corp. Provides Third Quarter 2024 Portfolio Update
Completed Seven Investments in New and Existing Portfolio Companies Representing $75.3 Million in Funded Investments MENLO PARK, Calif., Oct. 08, 2024 (GLOBE […]
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
REDWOOD CITY, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing […]
